NASDAQ · ORKA

Oruka Therapeutics, Inc.

Healthcare · Biotechnology

$99.55

Up+$1.86 (+1.87%)

Updated Nov 4, 2026, 11:21 PM

SID Score

6.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 1.13B
P/E ratio: -12.2
Dividend yield: 0.00%
52-week range: $31.32 – $115.52
Volume: 823.45K
Avg. volume: 480.54K

Price performance · ORKA

ORKA price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

Last close: $99.55
Period change: +24.16%
Period low: $71.93
Period high: $99.55

Daily close

View OHLC price history

ORKA OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Nov 3, 2026	$97.48	$101.41	$95.29	$99.55	823.45K
Nov 2, 2026	$98.85	$99.83	$94.285	$95.43	654.34K
Oct 30, 2026	$94.87	$97.60	$94.745	$96.87	634.04K
Oct 29, 2026	$97.04	$98.88	$95.255	$96.65	657.29K
Oct 28, 2026	$95.26	$98.45	$94.17	$95.97	798.19K
Oct 27, 2026	$89.02	$96.66	$89.02	$95.81	1.21M
Oct 26, 2026	$81.98	$93.42	$81.98	$90.33	1.94M
Oct 23, 2026	$81.15	$81.15	$79.07	$80.15	514K
Oct 22, 2026	$79.06	$82.145	$78.36	$81.15	589.93K
Oct 21, 2026	$79.97	$81.75	$79.48	$79.92	953.38K
Oct 20, 2026	$74.42	$79.90	$74.42	$79.09	787.72K
Oct 19, 2026	$72.40	$76.35	$72.30	$74.48	817.98K
Oct 16, 2026	$73.75	$74.26	$70.50	$71.93	1.39M
Oct 15, 2026	$75.53	$77.89	$73.15	$73.87	1.22M
Oct 14, 2026	$77.37	$78.57	$75.41	$76.68	685.3K
Oct 13, 2026	$79.47	$80.19	$78.18	$78.19	503.09K
Oct 12, 2026	$81.81	$82.95	$79.43	$80.35	547.92K
Oct 9, 2026	$77.24	$82.24	$77.00	$82.11	1.21M
Oct 8, 2026	$78.47	$80.19	$75.83	$77.28	1.23M
Oct 7, 2026	$79.01	$81.395	$78.52	$79.50	809.9K
Oct 6, 2026	$84.94	$84.94	$77.78	$80.18	1.12M

Latest ORKA news

The latest Smart Investors Daily articles mentioning ORKA.

analystOct 28, 2026

Guggenheim Reiterates Buy Rating on Oruka Therapeutics, Inc. (ORKA)

analystOct 28, 2026

Wedbush Reiterates Outperform Rating on Oruka Therapeutics, Inc. (ORKA)

sec filingOct 27, 2026

Oruka Therapeutics, Inc. (ORKA) Reports Material Event to SEC

Latest ORKA news

The latest Smart Investors Daily articles mentioning ORKA.

ORKA research

SEC Filings

Recent regulatory filings and source documents.

SEC filing history

Open a filing to view the original source document.

ORKA SEC filings
Filed	Form	Description	Accepted	Document
Nov 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Oct 26, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Oct 20, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Oct 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Oct 13, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Oct 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 21, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 21, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Sep 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 25, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 24, 2026	8-K	Form 8-K - Current report - Item 5.02 Item 9.01	—	Open source
Aug 17, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 14, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 14, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 10, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 9.01	—	Open source
Aug 10, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Jul 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 13, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 22, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
May 1, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Apr 30, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 8.01 Item 9.01	—	Open source
Apr 27, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01	—	Open source
Apr 17, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Apr 15, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Mar 12, 2026	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Jan 2, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 11, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Dec 11, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 9.01	—	Open source
Nov 12, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Oct 14, 2025	S-3/A	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	—	Open source
Oct 14, 2025	S-3/A	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	—	Open source
Oct 3, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Oct 3, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Sep 22, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 3.02 Item 7.01 Item 9.01	—	Open source
Sep 19, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Aug 11, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Jul 1, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 1, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 9.01	—	Open source
Jun 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source

Filed

Form

Description

Accepted

Document

Nov 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Oct 26, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Oct 20, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Oct 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Oct 13, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Oct 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 21, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 21, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Sep 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 25, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 24, 2026

8-K

Form 8-K - Current report - Item 5.02 Item 9.01

—

Open source

Aug 17, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 14, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 14, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 10, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 9.01

—

Open source

Aug 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Jul 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 13, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 22, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

May 1, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Apr 30, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 8.01 Item 9.01

—

Open source

Apr 27, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 8.01 Item 9.01

—

Open source

Apr 17, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Apr 15, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Mar 12, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Jan 2, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 11, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Dec 11, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 9.01

—

Open source

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Oct 14, 2025

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

—

Open source

Oct 14, 2025

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

—

Open source

Oct 3, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Oct 3, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Sep 22, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 3.02 Item 7.01 Item 9.01

—

Open source

Sep 19, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Aug 11, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Jul 1, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 1, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 9.01

—

Open source

Jun 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Guggenheim Reiterates Buy Rating on Oruka Therapeutics, Inc. (ORKA)

Wedbush Reiterates Outperform Rating on Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA) Reports Material Event to SEC

Featured By

Guggenheim Reiterates Buy Rating on Oruka Therapeutics, Inc. (ORKA)

Wedbush Reiterates Outperform Rating on Oruka Therapeutics, Inc. (ORKA)

Oruka Therapeutics, Inc. (ORKA) Reports Material Event to SEC